You are not currently logged in.
Access your personal account or get JSTOR access through your library or other institution:
The Ariel Project: A Prospective Cohort Study of Maternal-Child Transmission of Human Immunodeficiency Virus Type 1 in the Era of Maternal Antiretroviral Therapy
Russell B. Van Dyke, Bette T. Korber, Edwina Popek, Catherine Macken, Susan M. Widmayer, Arlene Bardeguez, I. Celine Hanson, Andrew Wiznia, Katherine Luzuriaga, Richard R. Viscarello, Steven Wolinsky and Ariel Core Investigators
The Journal of Infectious Diseases
Vol. 179, No. 2 (Feb., 1999), pp. 319-328
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30117270
Page Count: 10
Preview not available
In a prospective cohort study, clinical and biologic factors that contribute to maternal-child transmission of human immunodeficiency virus type 1 (HIV-1) were studied. HIV-infected pregnant women and their infants were evaluated prospectively according to a standardized protocol. Of 204 evaluable women, 81% received zidovudine during their pregnancy. The infection rate among the 209 evaluable infants was 9.1%. By univariate analysis, histologic chorioamnionitis, prolonged rupture of membranes, and a history of genital warts were significantly associated with transmission. Additional factors associated with transmission that approached significance included a higher maternal virus load at delivery and the presence of cocaine in the urine. In a logistic regression model, histologic chorioamnionitis was the only independent predictor of transmission. Despite a significantly higher transmission rate at one site, no unique viral genotype was found at any site. Thus, chorioamnionitis was found to be the major risk factor for transmission among women receiving zidovudine.
The Journal of Infectious Diseases © 1999 Oxford University Press